126 related articles for article (PubMed ID: 24073376)
1. Development of interferon γ-based immunocytokines targeting renal cancer.
Chen P; Balachandran S
Oncoimmunology; 2013 Jul; 2(7):e24964. PubMed ID: 24073376
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinoma.
Chen P; Nogusa S; Thapa RJ; Shaller C; Simmons H; Peri S; Adams GP; Balachandran S
PLoS One; 2013; 8(4):e61446. PubMed ID: 23613854
[TBL] [Abstract][Full Text] [Related]
3. NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.
Thapa RJ; Chen P; Cheung M; Nogusa S; Pei J; Peri S; Testa JR; Balachandran S
Mol Cancer Ther; 2013 Aug; 12(8):1568-78. PubMed ID: 23657944
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective.
Balachandran S; Adams GP
J Interferon Cytokine Res; 2013 Apr; 33(4):171-80. PubMed ID: 23570383
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation.
Zhang Y; Cheng J; Zhang J; Wu X; Chen F; Ren X; Wang Y; Li Q; Li Y
Biochem Biophys Res Commun; 2016 Sep; 477(4):761-767. PubMed ID: 27363341
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
7. Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe-Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding.
Haga S; Kanno A; Ozawa T; Morita N; Asano M; Ozaki M
Oncol Res; 2018 Apr; 26(3):503-513. PubMed ID: 28770700
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
Hess C; Neri D
Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
[TBL] [Abstract][Full Text] [Related]
9. 5-((7-Chloro-6-fluoro-1h-indol-3-yl) methyl)-3-methylimidazolidine-2,4-dione as a RIP1 inhibitor protects LPS/D-galactosamine-induced liver failure.
Li A; Yang Q; Lou G; Liu Y; Xia H; Chen Z
Life Sci; 2021 May; 273():119304. PubMed ID: 33662432
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
Front Immunol; 2018; 9():2905. PubMed ID: 30619269
[TBL] [Abstract][Full Text] [Related]
11. Extracts derived from a traditional Chinese herbal formula triggers necroptosis in ectocervical Ect1/E6E7 cells through activation of RIP1 kinase.
Chen X; Hu X; Liu L; Liang X; Xiao J
J Ethnopharmacol; 2019 Jul; 239():111922. PubMed ID: 31034957
[TBL] [Abstract][Full Text] [Related]
12. Emodin induced necroptosis in the glioma cell line U251 via the TNF-α/RIP1/RIP3 pathway.
Zhou J; Li G; Han G; Feng S; Liu Y; Chen J; Liu C; Zhao L; Jin F
Invest New Drugs; 2020 Feb; 38(1):50-59. PubMed ID: 30924024
[TBL] [Abstract][Full Text] [Related]
13. Utilizing Immunocytokines for Cancer Therapy.
Runbeck E; Crescioli S; Karagiannis SN; Papa S
Antibodies (Basel); 2021 Mar; 10(1):. PubMed ID: 33803078
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis.
LaRocca TJ; Sosunov SA; Shakerley NL; Ten VS; Ratner AJ
J Biol Chem; 2016 Jun; 291(26):13753-61. PubMed ID: 27129772
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity.
Chen J; Kuroki S; Someda M; Yonehara S
J Biol Chem; 2019 Aug; 294(32):11994-12006. PubMed ID: 31217278
[TBL] [Abstract][Full Text] [Related]
16. RIP1 Perturbation Induces Chondrocyte Necroptosis and Promotes Osteoarthritis Pathogenesis
Cheng J; Duan X; Fu X; Jiang Y; Yang P; Cao C; Li Q; Zhang J; Hu X; Zhang X; Ao Y
Front Cell Dev Biol; 2021; 9():638382. PubMed ID: 33937236
[TBL] [Abstract][Full Text] [Related]
17. Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.
Ebbinghaus C; Ronca R; Kaspar M; Grabulovski D; Berndt A; Kosmehl H; Zardi L; Neri D
Int J Cancer; 2005 Aug; 116(2):304-13. PubMed ID: 15800913
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.
Thapa RJ; Basagoudanavar SH; Nogusa S; Irrinki K; Mallilankaraman K; Slifker MJ; Beg AA; Madesh M; Balachandran S
Mol Cell Biol; 2011 Jul; 31(14):2934-46. PubMed ID: 21576359
[TBL] [Abstract][Full Text] [Related]
19. RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).
Liu Y; Liu T; Lei T; Zhang D; Du S; Girani L; Qi D; Lin C; Tong R; Wang Y
Int J Mol Med; 2019 Sep; 44(3):771-786. PubMed ID: 31198981
[TBL] [Abstract][Full Text] [Related]
20. RIP1-Dependent Programmed Necrosis is Negatively Regulated by Caspases During Hepatic Ischemia-Reperfusion.
Rosentreter D; Funken D; Reifart J; Mende K; Rentsch M; Khandoga A
Shock; 2015 Jul; 44(1):72-6. PubMed ID: 26009812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
